Signaling Pathway
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
| Discription | LFM-A13 is a potent and selective inhibitor of Btk with IC50 of 17.2 uM; also inhibits PLK3 with IC50 of 7.2 uM. | ||
|---|---|---|---|
| Targets |
|
| Catalog Num | A16261 |
|---|---|
| Formula | C11H8Br2N2O2 |
| Molecular Weight | 360 |
| CAS Number | 244240-24-2 |
| SMILES | C/C(O)=C(/C(O)=N/C1=C(Br)C=CC(Br)=C1)C#N |
| Synonyms | LFM A13 |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | Warmed: 67 mg/mL (186.11 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 27.78 mL | 138.89 mL | 277.78 mL |
| 0.5 mM | 5.56 mL | 27.78 mL | 55.56 mL |
| 1 mM | 2.78 mL | 13.89 mL | 27.78 mL |
| 5 mM | 0.56 mL | 2.78 mL | 5.56 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
